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Laminin variants: Why, where and when? Laminin is a member of a
family of proteins that are composed of three subunits, one heavy chain
and two light chains. Five subunits in the laminin family have been
cloned and sequenced so far. These include two heavy chains, the
laminin A chain and the merosin M chain, and three light chains, BI,
B2, and S. These five subunits can form four different laminin variants:
A-B1-B2, A-S-B2, M-Bl-B2, and M-S-B2, all having the B2 chain in
common. Major basement membranes in tissues contain at least one of
the four laminin variants. For example, the adult muscle and nerve
basement membranes contain M-B l-B2, smooth muscle contains A-B1-
B2, the myotendinous junction and the trophoblast basement mem-
brane in the placenta contain M-S-B2, and blood vessels contain
A-Bl-B2 and/or A-S-B2. In the brain, the merosin M chain is present in
association with neuronal fibers. The four members of the laminin
family interact with cells in a similar manner. Thus, they promote
outgrowth of neurites from neuronal cells and promote attachment and
spreading of non-neuronal cells. The interaction of cells with laminins
is mediated largely by integrin type receptors, including integrins
alphalbetal, alpha2betal, alpha3betal, and alpha6betal. The expres-
sion of the different laminin-like proteins is developmentally regulated.
The laminin A chain is the first heavy chain expressed. It is present in
the striated muscle basement membrane in the fetus, but its expression
is gradually decreased during development and it is restricted to the
synaptic basement membrane in the adult. In contrast, the expression
of the M chain in muscle is induced around birth and increases until it
is the predominant heavy chain made in the mature muscle. The
differential expression of laminin variants in tissues during different
times of development suggest that the laminin variants have specialized
functions. The structural and functional comparisons of existing vari-
ants as well as of variants yet to be discovered should further our
understanding of the effects of basement membranes on cell behavior.
Much has been learned about the basement membrane pro-
tein laminin since its identification [1, 2], in particular about its
structure. The prototype laminin was characterized and isolated
from embryonic cell lines such as mouse endodermal cells, the
mouse Engeibreth-HoIm-Swarm sarcoma, and rat yolk sac
tumors and cell lines [2—6]. Laminin is a large protein, >800
kDa, composed of three subunits, named A, B 1, and B2. The
subunits assemble into a cross-like molecule with one long and
three short arms. All three subunits have been cloned and
sequenced from several species (see below), and this sequence
information together with information derived using biochem-
istry and electron microscopy have produced a relatively clear
picture of the structure of the molecule [7—10].
Less is understood about the function of laminin. Numerous
reports show that laminin promotes the adhesion, growth,
motility, and differentiation of cells [8, 10], but the mecha-
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nism(s) by which laminin affects the behavior of the cells
remains to be determined. A major factor contributing to the
relatively slow progress in the study of function as opposed to
structure of laminin is obviously the degree of complexity of the
laminin molecule. Because of its large size and its relative
protease resistance, it has been difficult to dissect the molecule
by making small fragments. The well characterized mouse
laminin E8 fragment [11, 12], which seems to contain the major
cell binding activity of intact laminin [13—15], is still a very large
portion of the molecule. And it has been difficult to study any
potential activities of the individual subunits of laminin. The
three laminin subunits interact to form a coiled coil structure,
stabilized by S-S bonds, making the separation of the subunits
while still maintaining structure just about impossible. It can be
expected that molecular biology techniques in combination with
biochemistry will soon lead to progress in defining active sites
in laminin.
Studying cellular receptors for laminin may help in the
understanding of the biological function of laminin. The dem-
onstrations of an increasing number of cellular receptors, which
bind to laminin but which are also rather promiscuous in that
they bind other proteins too, may seem at present to have
complicated rather than clarified the picture [16—18]. A large
number of the laminin receptors belong to the family of the
biochemically well characterized integrins [16, 17]. The mech-
anism for signal transduction via these integrins is not yet
known, neither is the biological significance of the large number
of laminin binding integrins understood. However, the rapid
progress in the integrin field is likely to soon lead to new
avenues in laminin research.
Identification of laminin variants
It has become apparent that laminin is a member of a family
of proteins and that laminin is not a ubiquitous basement
membrane component as was previously thought for the "clas-
sical" laminin. Instead, the various members of the laminin
family are expressed in different tissues and at different times
during development. Early immunochemical and biochemical
evidence for laminin variants [19, 20] has recently been con-
firmed by molecular approaches [21, 221. Sanes and collabora-
tors [21] showed that the basement membrane at the neuromus-
cular junction contains components that are unique when
compared to the major portion of the muscle basement mem-
brane. One unique antigen was cloned and sequenced and found
to be a polypeptide homologous to the Bi subunit of laminin.
Similarly, placenta, muscle, and Schwann cell basement mem-
branes contained a distinct antigen as detected by monoclonal
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Fig. 1. Schematic representation of four
laminin variants with their respective tissue
localization.
antibodies [23]. This antigenic determinant was associated with
a new protein that was named merosin. Subsequently, it was
discovered that the polypeptide with the antigenic epitope was
related to the laminin A chain [221 and was part of a laminin-like
molecule. We now call this A-like chain M since it is most likely
identical to the polypeptide previously called "M laminin" [20].
Observations from in vitro cell culture suggest that additional
subunits, or different stochiometric complexes of known sub-
units, may occur. Several reports document the presence of
high molecular weight complexes containing the smaller B
subunits but lacking a large A or A-like subunit [24—281. The
nature of these complexes and their pattern of tissue expression
are not yet known. One well studied cell line that makes this
kind of laminin is the Schwannoma line RN22 [24-26]. This line
has been studied because it makes relatively large amounts of a
neurite-promoting factor, that subsequently was shown to be
related to laminin. However, no subunit larger than the B
subunits can be detected in preparations of the neurite promot-
ing factor, and in electron microscopy after rotary shadowing,
the isolated laminin-like protein contains mainly molecules with
two instead of three arms. Whether this two-armed laminin-like
protein is a new protein or a spliced or fragmented variant of
one of the known variants is not yet clear. However, cultured
RN22 cells contain the merosin M chain polypeptide as evi-
denced by immunoblotting techniques [29].
Expression of laminin and laminin variants
Subunit-specific monoclonal antibodies have been very im-
portant in generating information about composition and distri-
bution of laminin-like proteins. Isolation of laminin and laminin
variants from placenta by affinity chromatography with mono-
clonal antibodies showed the presence of at least four variants
in this tissue [30, 31]. The experiments showed that the A and
M chains are present in different molecules, but that these
heavy chains associate with the same light chains, Bl and B2.
Furthermore, the homologue of the B 1 chain, the S chain, can
replace the Bl chain in laminin and merosin. The B2 chain is
present in all known complexes. Thus, members of the laminin
family are heterotrimers containing a Bi or Bi-like (S) chain, a
B2 chain, and an A or A-like (M) chain (Fig. 1).
The distribution of laminin subunits in tissues as evidenced
by immunofluorescence confirm the data obtained from analysis
of isolated laminin variants: all major basement membranes
contain at least three subunits in the laminin family, one heavy
chain and two light chains. Laminin (with an A chain) is usually
not present in the same basement membranes as merosin (the
laminin variant with an M chain). Figure 2 shows an example of
the different distributions of the A and the M chain in heart
muscle; the A chain is present in blood vessels while the M
chain is present in the muscle basement membrane. A summary
of the distribution of the different laminin variants is shown in
Figure 1.
Basement membrane components are know to have a long
half-life in vivo. Detection of the protein in tissue may therefore
not accurately reflect the synthesis in the tissue and even small
amounts of newly synthesized protein could have important
effects on the cells. Several studies have shown discordant
expression of the subunits of the classical laminin [32—35]. In
most cases the lack of mRNA for the A chain may now be
explained by the fact that the M chain is the heavy chain
synthesized in that tissue. We have done some preliminary
studies to determine the expression of the M chain in various
tissues and have found that there is a large increase in its
synthesis in muscle after birth in the rat. The peak of synthesis
seems to be around three weeks of age, a time when maximum
growth occurs (Day and Engvall, unpublished observations).
Structure of laminin variants
Sequencing the five subunits in the laminin family, A, M, Bl,
B2, and S from cDNA showed that they are all homologous [21,
22, 36—39]. The larger size of the A and M chain is due to an
additional large globular domain at their C-terminal end, the g
domain. The percentage of interspecies sequence identity be-
tween the mouse and human A chains is about 76% [39]. On the
other hand, there is significant divergence between the different
subunits within a species. The percentage of sequence identity
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between the human A and M chains is only about 40 [22, 39]. It
is clear then that the A and M chains have evolved quite
distinctly and that they may have distinct functions. The nature
of these functions is not known.
The BI and B2 light chains share 25%sequence identity. This
is about the same as the identity between either one of the B
chains and the A chain. The S chain is most similar to the Bl
chain, sharing about 50% of the sequence [211. From these
homologies, one might hypothesize that a primordial gene has
duplicated generating A, Bi, and B2; since laminin A-Bl-B2 is
the first laminin variant in the embryo, this may be the earliest
laminin trimer. M and S seem to be the result of more recent
gene duplications. Do these chains only represent fine tuning of
the existing function of laminin, or have they evolved indepen-
dent activities? Hopefully, information on this will emerge in
the near future.
A couple of structural differences between laminin A-B 1 -B2
and M-Bl-B2 may be of physiological importance. The A chain
in tissue is found in its intact 400 kDa form while the M chain is
found in two pieces, one of about 300 kDa and the other of 80
kDa [221. Although not covalently bound, the smaller piece of
the M chain remains associated with the M-Bl-B2 complex,
since it is present after purification of the protein. The smaller
piece contains the last three repeats in the globular g domain.
Whether the fragmentation of the M chain is physiological or an
artefact of processing of the tissue before analysis or isolation is
not clear. Aside from the preferential cleavage of merosin in the
C-terminal region, merosin appears in other regions to be more
resistant to proteolysis than the classical laminin. Proteolytic
digestion of merosin from heart gives a larger protease resistant
fragment than digestion of laminin [401. The large merosin
fragment retains the major portion of the long arm, while
laminin is cleaved 1/3 down the long arm to produce the
fragment E8.
Function of laminin variants
Laminin promotes cell attachment and neurite outgrowth in
short-term in vitro assays. The major cell attachment site and
the neurite promoting site in laminin is localized to the end of
the long arm [12—15]. This region is where integrins a3/3l and
a6/31 have been shown to bind [41—44]. Another site of cell
attachment and binding of the integrin a! 131 is located near the
center of the laminin cross in mouse laminin [42, 44]. Mouse
laminin has an arg-gly-asp sequence in the A chain in this
region, and this recognition sequence for cell attachment [45]
may be part of the active site. Human laminin A chain lacks this
sequence and there is no report yet showing that human laminin
binds cells and/or the cx! /31 integrin via a site at the center of the
cross. The human A chain, but not the M chain, has an
arg-gly-asp sequence in the globular g domain. Since laminin
and merosin have similar cell binding properties it seems
unlikely that the arg-gly-asp sequence in the g domain plays a
major role in the cell attachment activity of laminin.
Do all laminin variants have the same effect on cells? To
address this question, we compared the cell attachment and
neurite-promoting activities of the laminin variants A-B I -B2
and M-Bl-B2 [29]. The "classical" laminin A-B1-B2 was iso-
lated from the rat L2 yolk sac tumor and the merosin M-B I -B2
was isolated from placenta. We also compared large fragments
of classical laminin and merosin with these chain compositions
from pepsin digests of placenta. There were no detectable
differences in the activities of these preparations when a panel
of different cell lines were tested for attachment to and spread-
ing on the proteins. In addition, by determining the spectrum of
integrin-type receptors on the different cells, a tentative con-
clusion was made that the laminin binding integrins in the /31
family are able to bind both variants.
The two laminin variants were also compared in their capac-
ity to promote outgrowth of neurites from eight-day ciliary
ganglion neurons. No differences between the two proteins
were detected in these assays either. Consequently, no major
difference in cell binding activities of laminin has so far been
detected when the M chain is substituting for the A chain in
laminin.
There are some indications that substituting the S chain for
the B 1 chain might change the activity of laminin. Laminin
A-S-B2 is present at the neuromuscular junction in the synaptic
basement membrane. This basement membrane is known to
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Fig. 2. Localization of laminin A chain (A)
and merosin M chain (B) in sections of adult
rabbit heart.
Engvall: Laminin variants 5
have unique properties based on the fact that regenerating
nerves preferentially form contacts with muscle at the previ-
ously existing synaptic sites. In accordance with the hypothesis
that the synapses have unique properties, the S chain was found
to contain sequences not present in the B! chain that influence
the attachment of neurons [46].
Future prospects
The nature of the remarkable effects of laminin on cells
remains largely unsolved. How many cell binding sites does
laminin contain? What are the receptors binding to these sites
and how do these receptors transmit their signals to the cells?
Once these questions begin to be answered, one can expect the
next phase of laminin research to begin. It is clear that laminin
is a molecule of profound importance during development and
regeneration and that therapies based on laminin may be
developed in the future. These may include synthetic or recom-
binant peptides modeled after cell interactive sites in laminin to
be used as agonists or antagonists of laminin receptors. Alter-
native ways of affecting laminin-cell interactions may include
laminin ligands other than receptors, for example proteoglycans
that bind to laminin and block cell interaction [47]. They may
also include means of up- or down-regulating specific receptors
for laminin.
Once all the interacting molecules are known, one should be
able to control cell behavior in many situations, such as in
regeneration in acute or degenerative diseases of the nervous
system, in wound healing, and in affecting growth and migration
of cells in normal and malignant diseases.
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